Iovance Biotherapeutics, Inc. (IOVA)

Iovance Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	164.19	114.89	231.73	78.23	67.33	13.97
Short-Term Investments	233.3	164.98	240.11	426.18	562.11	293.11
Cash & Short-Term Investments	397.49	279.87	471.85	504.41	629.44	307.08
Cash Growth	9.99%	-40.69%	-6.46%	-19.86%	104.97%	-34.46%
Receivables	55.77	0.15	-	-	-	-
Inventory	38.58	10.37	-	-	-	-
Prepaid Expenses	6.74	17.46	7.27	3.55	6.66	9.41
Total Current Assets	498.58	307.85	479.12	507.96	636.1	316.49
Property, Plant & Equipment	179.26	176.55	178.25	169.92	113.92	19.23
Long-Term Investments	-	-	-	91.59	-	-
Other Intangible Assets	306.64	229.26	-	-	-	-
Other Long-Term Assets	6.64	66.7	6.62	7.87	18.44	8.93
Total Assets	991.12	780.35	663.98	777.33	768.46	344.66
Accounts Payable	31.69	33.12	26.6	27.38	13.51	15.57
Accrued Expenses	72.76	66.97	45.79	51.91	30.73	16.27
Current Portion of Leases	11.55	7.78	12.59	5.06	6.28	7.25
Other Current Liabilities	2.06	2.44	6.51	4.86	4.34	-
Total Current Liabilities	118.06	110.31	91.49	89.2	54.87	39.08
Long-Term Debt	1	1	1	1	-	-
Long-Term Leases	66.39	67.09	71.86	65.47	45.38	4.25
Long-Term Deferred Tax Liabilities	32.22	17.35	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	11.71	2.35
Total Liabilities	217.66	195.74	164.34	155.67	111.96	45.68
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,063	2,594	2,069	1,795	1,487	869.35
Retained Earnings	-2,306	-2,012	-1,568	-1,172	-830.19	-570.61
Comprehensive Income & Other	16.24	2.53	-0.9	-0.6	0.02	0.22
Total Common Equity	773.45	584.61	499.64	621.66	656.49	298.97
Shareholders' Equity	773.46	584.61	499.64	621.66	656.5	298.97
Total Liabilities & Equity	991.12	780.35	663.98	777.33	768.46	344.66
Total Debt	78.94	75.86	85.45	71.53	51.66	11.5
Net Cash (Debt)	318.55	204.01	386.4	432.88	577.78	295.58
Net Cash Growth	13.00%	-47.20%	-10.74%	-25.08%	95.47%	-36.91%
Net Cash Per Share	1.15	0.87	2.43	2.82	4.18	2.38
Filing Date Shares Outstanding	304.78	279.31	224.24	157.17	146.98	126.5
Total Common Shares Outstanding	304.62	256.14	187.81	157	146.87	126.41
Working Capital	380.52	197.54	387.63	418.76	581.23	277.41
Book Value Per Share	2.54	2.28	2.66	3.96	4.47	2.37
Tangible Book Value	466.81	355.35	499.64	621.66	656.49	298.97
Tangible Book Value Per Share	1.53	1.39	2.66	3.96	4.47	2.37
Machinery	34.32	33.27	31.79	14.87	5.41	5.25
Construction In Progress	29.66	24.1	9.12	35.78	56.76	5.42
Leasehold Improvements	76.85	76.8	74.31	57.82	2.57	2.37

Source: S&P Capital IQ. Standard template. Financial Sources.